Skip to main content

Table 3 Factors associated with refusal to participate in clinical trial subcategories (adjusted (aOR) odds ratios with 95% confidence intervals [95%CI] and associated significance estimates (p-values) for variables used to predict refusal)

From: Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?

Trial Subcategory

Willingness to participate rate

Factors associated with refusal to participate

aOR [95%CI]

p-value

Drug Pre-marketing

246/838 (29%)

- Gender (female)

0.64 [0.47–0.88]

0.006

- Poor knowledge about own disease

0.58 [0.39–0.88]

0.010

- Distrust-group membership

0.45 [0.32–0.63]

< 0.001

Drug Post-marketing

630/838 (75%)

- Gender (female)

0.66 [0.50–0.88]

0.004

Drug (pre or post-marketing)

638/838 (76%)

- Gender (female)

0.67 [0.49–0.93]

0.017

Public sponsor

723/838 (86%)

- Inactive employment status

0.56 [0.40–0.78]

< 0.001

Pharmaceutical sponsor

91/838 (11%)

- Age

0.96 [0.95–0.98]

< 0.001

- Distrust-group membership

0.25 [0.14–0.44]

< 0.001